Surfing the MASH Tsunami Podcast Artwork Image

Surfing the MASH Tsunami

SurfingNASH.com

Driving the Discussion in Fatty Liver Disease. Join hepatology researcher and Key Opinion Leader Jörn Schattenberg, Liver Wellness Advocate Louise Campbell, and Forecasting and Pricing Guru Roger Green and a global group of Key Opinion Leaders and patient advocates as they discuss key issues in Fatty Liver disease, including epidemiology, drug development, clinical pathways, non-invasive testing, health economics and regulatory issues, from their own unique perspectives on the Surfing the MASH Tsunami podcast. #MASH #MAFLD #FattyLiver #livertwitter #AASLD #GlobalLiver #NoNASH #EASL

Episodes
S5 - E11 - Life With Rezdiffra: Early Impact On MASH Patient Treatment and MASLD Clinical TrialsApril 17, 2024
Episode artwork
S5 - E10 - Lessons And Insights On Using Basic EHR Data To Screen For Target MASLD PatientsApril 15, 2024
Episode artwork
S5 - E9.6 - From The Vault: An Earlier Look At Screening In The Clinical Care PathwayApril 07, 2024
Episode artwork
S5 - E9.5 - In-Office Screening Post-Rezdiffra: The Importance Of Predictive BiomarkersApril 07, 2024
Episode artwork
S5 - E9.4 - In-office MASLD Screening and the Clinical Care PathwayApril 07, 2024
Episode artwork
S5 - E9.3 - How Will Increased Access To In-Office Scanning Improve MASLD Therapy:April 06, 2024
Episode artwork
S5 - E9.2 - VCTE Studies Demonstrate That Multiple Nutrition Interventions Can Support MASLD PatientsApril 06, 2024
Episode artwork
S5 - E9.1 - VCTE As A Prognostic And Therapeutic Tool For MASLDApril 06, 2024
Episode artwork
S5 - E9 - Value of VCTE Or Other In-Office MASLD Monitoring April 04, 2024
Episode artwork
S5 - E8 - Changing Patient Incentives For Participating In MASH Clinical TrialsApril 01, 2024
Episode artwork
S5 - E7.6 - MASLD Patient Advocates' Recommendations for Others after Rezdiffra ApprovalMarch 24, 2024
Episode artwork
S5 - E7.5 - Will Increasing the Focus on MASH via Rezdiffra Overwhelm the Healthcare System?March 24, 2024
Episode artwork
S5 - E7.4 - How MASH patient advocates plan to support RezdiffraMarch 24, 2024
Episode artwork
S5 - E7.3 - Patient advocacy and the Rezdiffra labelMarch 23, 2024
Episode artwork
S5 - E7.1 - Rezdiffra is approved! How patient and their advocates processed the news about the first MASH drugMarch 23, 2024
Episode artwork
S5 - E7.2 - Identifying the target MASH patients for RezdiffraMarch 22, 2024
Episode artwork
S5 - E7 - MASLD Patient Advocates Celebrate Rezdiffra and Discuss the FutureMarch 20, 2024
Episode artwork
S5 - E6.6 - Closing Question From The Episode On Rezdiffra, The First MASH DrugMarch 19, 2024
Episode artwork
S5 - E6.5 - BioPharma Industry Takeaways ForBioPharma Industry Takeaways From The Rezdiffra Launch The Rezdiffra LaunchMarch 19, 2024
Episode artwork
S5 - E6.4 - Finding The MASH Patients That Are The Initial Rezdiffra TargetsMarch 19, 2024
Episode artwork
S5 - E6.3 - Staging and screening patients for Rezdiffra using NITsMarch 18, 2024
Episode artwork
S5 - E6.2 - How Approval Of Rezdiffra,The First MASH Drug, Might Improve Patient Adherence To Lifestyle RecommendationsMarch 18, 2024
Episode artwork
S5 - E6.1 - Rezdiffra Is Approved! How Key Opinion Leaders Processed The News About The First MASH DrugMarch 18, 2024
Episode artwork
S5 - E6 - Rezdiffra Is Here! Key Opinion Leaders React To The First MASH Drug ApprovalMarch 16, 2024
Episode artwork
S5 - E5.6 - From The Vault: Tsunami's First Look At MASEF, A Major New NITMarch 10, 2024
Episode artwork